Science News

Arbaclofen Shows Promise for Treating Core Symptoms of Autism

Compound advances into larger clinical trials; could pave the way for other future medicines as well

... More...

CDC Revises Estimate of Autism Prevalence: 1 in 88

Continuing increase in prevalence reaffirms public-health crisis

... More...

Mounting Evidence of Critical Need for Adult Transition Support

Young adults with autism less likely than any other disability group to be employed or enrolled in higher education 

... More...

Deeper Understanding of Link between Chemical Pollutants and Autism

The year brought advances in understanding whether and how chemical pollutants affect brain development in ways that may predispose to autism

... More...

Insights into Immune Changes & Autism

Researchers produce autism behaviors in mice by mimicking infection during pregnancy; reverse symptoms by resetting offspring’s immune system

... More...

Discovery of Pre-symptom Marker of Autism

Researchers use MRI to reveal differences in the brain’s white matter in infants as young as 6 months 

... More...

Early Intervention Program Alters Brain Activity in Children with Autism

Clinical study of Early Start Denver Model intervention shows that it improves not only social skills, but also brain responses to social cues

... More...

Top Ten Autism Research Advances of 2012

In 2012, autism dominated headlin... More...

Autism Speaks awards $2 million grant to Delivering Scientific Innovation for Autism LLC (DELSIA) for partnership with Seaside Therapeutics to Develop Innovative Autism Treatments

New York, N.Y. (December 3, 2012) – Autism Speaks and Delivering Scientific Innovation for Autism, LLC (DELSIA), its non-profit affiliate, announced today a partnership between DELSIA and Seaside Therapeutics (Cambridge, Mass.) that aims to ... More...

Syndicate content